Royalty Pharma plcRoyalty Pharma plcRoyalty Pharma plc

Royalty Pharma plc

No trades
See on Supercharts

Price target

41.710.000.00%
The 7 analysts offering 1 year price forecasts for RPRX have a max estimate of — and a min estimate of —.

Analyst rating

Based on 11 analysts giving stock ratings to RPRX in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


RPRX EPS for the last quarter is 0.96 USD despite the estimation of 0.97 USD. In the next quarter EPS is expected to reach 0.93 USD. Track more of Royalty Pharma plc financials and stay on top of what is up with the company.
In the next quarter Royalty Pharma plc revenue is expected to reach ‪696.92 M‬ USD. Check out Royalty Pharma plc revenue and earnings and make informed decisions.
According to analysts, RPRX price target is 41.71 USD with a max estimate of 51.00 USD and a min estimate of 28.00 USD. Check if this forecast comes true in a year, meanwhile watch Royalty Pharma plc stock price chart and keep track of the current situation with RPRX news and stock market news.
We've gathered opinions of 11 analysts rating RPRX stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.